Skip to content

Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit

Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03934112
Acronym
PATMORE
Enrollment
150000
Registered
2019-05-01
Start date
2020-01-03
Completion date
2026-12-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transfusion Related Complication

Brief summary

This study will allow correlating transfusion monitoring and patients' prognostic according to the chosen outcome criteria. These data could thus represent a basis for transfusion recommendations, except for intensive care and vital emergencies. It will also bring information about the actual transfusion monitoring in intensive care unit (ICU), in the period following the stay in the ICU and after hospital discharge.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient admitted to medical and surgical resuscitation units of Besançon and Dijon university hospitals, all causes considered * Patient admitted between 1st January 2012 to 31st December 2017

Design outcomes

Primary

MeasureTime frameDescription
Survival at 90 days after leaving ICUDay 90All-cause mortality 90 days after leaving ICU

Countries

France

Contacts

Primary ContactMaxime Desmarets, PhD
maxime.desmarets@univ-fcomte.fr0033 381 218 359

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026